Omeprazole Drug Interactions: A Complete Guide to FDA-Documented Risks
Learn about omeprazole drug interactions backed by FDA labeling. Understand which medications are contraindicated and what to discuss wit...
Digoxin is a heart medication with a narrow margin between an effective dose and a toxic dose. Because of this, many drugs and supplements can dangerously raise digoxin levels in your blood or interfere with how your body processes it. According to FDA drug labeling data, there are multiple documented serious interactions with digoxin, including several contraindicated combinations that should be avoided altogether. This guide explains which drugs interact with digoxin, why those interactions happen, and what monitoring you should expect.
Digoxin is a cardiac glycoside—a medication derived from the foxglove plant—used to treat heart failure and certain irregular heartbeats (atrial fibrillation). It works by increasing the force of heart contractions and, in some cases, slowing the heart rate. Because digoxin has a relatively narrow therapeutic window, small changes in blood levels can mean the difference between benefit and harm. Your body eliminates digoxin primarily through the kidneys, and anything that slows kidney function or changes how your body processes the drug can raise digoxin to toxic levels.
Toxic digoxin levels can cause serious, life-threatening problems including severe arrhythmias (abnormal heart rhythms), nausea, confusion, and in extreme cases, cardiac arrest. For this reason, doctors often monitor digoxin levels with blood tests and watch carefully for signs of toxicity, especially when other medications are added or changed.
FDA drug labeling identifies several drug combinations with digoxin that are contraindicated—meaning they should be avoided because the risks are too great. These are not interactions to manage with careful monitoring; they are combinations that should not happen unless there is no alternative and a physician determines the benefit outweighs the extreme risk.
Lasmiditan is a medication used to treat acute migraine. According to FDA labeling, coadministration of lasmiditan with digoxin is contraindicated. The mechanism is P-glycoprotein transporter inhibition. P-glycoprotein is a cellular pump that helps remove digoxin from your body. When lasmiditan blocks this pump, digoxin levels rise, increasing the risk of serious toxicity. If you take digoxin and have migraines, discuss alternative migraine treatments with your physician before starting lasmiditan.
FDA labeling documents contraindicated interactions between digoxin and three forms of potassium phosphate supplements:
The reason is severe and potentially fatal hyperkalemia—dangerously high blood potassium. Potassium supplements directly raise potassium levels, and this additive effect creates a compounding problem: high potassium makes digoxin more likely to cause arrhythmias and toxicity. The combination is forbidden. If you take digoxin and have low potassium, your doctor must prescribe a different potassium replacement method and monitor blood potassium carefully.
Calcium gluconate (an injectable calcium supplement) is contraindicated with digoxin. The mechanism involves two dangers: (1) calcium gluconate can cause hypercalcemia (high blood calcium), which directly increases digoxin toxicity risk, and (2) there is a synergistic arrhythmia potential, meaning the combination promotes abnormal heart rhythms beyond what either drug alone would cause. FDA labeling states that if concurrent administration is unavoidable, the calcium gluconate must be given slowly with electrocardiogram (ECG) monitoring to watch for dangerous heart rhythm changes.
Calcium chloride (another form of injectable calcium) carries similar contraindicated status. Like calcium gluconate, it can cause hypercalcemia and synergistic arrhythmias. FDA guidance emphasizes that concomitant use should be avoided; if unavoidable, ECG monitoring is mandatory.
In addition to contraindicated combinations, FDA labeling identifies several major interactions where drugs can be used together but demand careful oversight.
Spironolactone is a potassium-sparing diuretic often used in heart failure alongside digoxin. However, spironolactone increases the half-life of digoxin, meaning digoxin stays in your body longer and accumulates to higher levels. This leads to increased serum digoxin concentration and risk of digitalis toxicity. Additionally, spironolactone raises potassium levels, adding another layer of toxicity risk. When used together, your doctor will typically order digoxin level checks and may reduce the digoxin dose. Spironolactone combined with hydrochlorothiazide carries the same major interaction with digoxin.
Alprazolam is a benzodiazepine anxiolytic (anti-anxiety medication). According to FDA labeling, concomitant use increases the risk of digoxin toxicity. The source labeling does not specify a detailed mechanism. Because both drugs can affect the nervous system and digoxin's metabolism, the combination warrants cautious use and potential digoxin level monitoring. If you take digoxin and need an anxiolytic, discuss whether alprazolam is appropriate or whether an alternative is safer.
Some IV fluid preparations contain electrolytes including calcium chloride (along with sodium chloride, sodium lactate, potassium chloride, and dextrose). FDA labeling advises that when digoxin patients receive such calcium-containing IV solutions, the volume or rate of administration should be reduced due to increased risk of digoxin toxicity. This is a practical concern in hospital and emergency settings where calcium-containing fluids might be ordered. If you are hospitalized or receive IV fluids while taking digoxin, confirm with the clinical team that the IV solution composition is appropriate.
Understanding the "why" behind digoxin interactions helps you recognize potential risks and communicate effectively with your healthcare team.
P-glycoprotein inhibition: P-glycoprotein is a protein pump in cells that actively removes digoxin from your body, especially in the intestines and kidneys. When a drug blocks this pump (as lasmiditan does), digoxin accumulates because it is not being cleared efficiently. Higher levels mean higher toxicity risk.
Electrolyte disturbances: Potassium and calcium are critical for heart rhythm. High potassium and high calcium both increase the sensitivity of the heart to digoxin's toxic effects. When you combine a drug that raises potassium or calcium with digoxin, you create a dangerous two-fold problem: the electrolyte imbalance itself and digoxin's amplified toxicity in that environment.
Altered half-life: The half-life of a drug is the time it takes for your body to eliminate half of a dose. Spironolactone increases digoxin's half-life, meaning digoxin is cleared more slowly. If you keep taking the same dose while clearance slows, the drug accumulates. Doctors adjust this by reducing the digoxin dose or spacing doses further apart.
Unknown mechanisms: For some interactions, like alprazolam, the exact mechanism is not spelled out in FDA labeling. The interaction is documented and real, but the underlying reason may involve complex metabolic or physiologic interactions that have not been fully characterized.
Scenario 1: Migraine Treatment in a Digoxin Patient
A 68-year-old woman with atrial fibrillation takes digoxin 0.25 mg daily. She develops frequent migraines and her neurologist recommends lasmiditan. She asks her pharmacist if it is safe to combine. The pharmacist checks FDA interaction data and finds that lasmiditan is contraindicated with digoxin because it blocks P-glycoprotein, preventing digoxin from being cleared. The pharmacist alerts the patient and her doctor. The doctor either switches to a different migraine medication or, if lasmiditan is essential, might discontinue digoxin temporarily (if clinically feasible) or choose a different heart rhythm medication. This is a clear case where the contraindication overrides convenience.
Scenario 2: Managing Heart Failure and Anxiety
A 75-year-old man with heart failure takes digoxin and develops anxiety symptoms. His primary care doctor considers alprazolam. Because the interaction is documented as major but not contraindicated, the doctor might proceed cautiously: prescribing a low starting dose of alprazolam, ordering a baseline digoxin level, and planning a repeat digoxin level in 1–2 weeks to ensure it has not risen into the toxic range. The patient is counseled to report dizziness, nausea, confusion, or palpitations immediately. This is an example of a major interaction that can be managed with vigilant monitoring and dose adjustment.
If you take digoxin, you should recognize early warning signs of toxicity, especially when starting a new medication or if a dose is changed:
If you experience any of these symptoms, contact your doctor or pharmacist immediately. Do not stop taking digoxin on your own, but report the symptom urgently so your healthcare team can check your digoxin level and adjust your dose if needed.
If you take digoxin, the safest next step is to review your complete medication list—including over-the-counter drugs, supplements, and herbal products—with your pharmacist or physician. Visit checkdruginteractions.com to search your specific medications and see documented interactions in plain language. Never start, stop, or change any medication without first discussing it with your healthcare team. Your pharmacist is your best resource for confirming that any new drug or supplement is safe to combine with digoxin, and your doctor can order digoxin level tests and adjust your dose as needed when interactions are discovered. Open communication and regular monitoring are the keys to safe, effective digoxin therapy.
CDI checks every pair across up to 20 drugs — backed by FDA and NIH data.
Drug interaction data sourced from U.S. FDA drug labeling via openFDA and the U.S. National Library of Medicine (NLM), National Institutes of Health. For informational purposes only. Always consult your pharmacist or physician before making any medication decisions.
Learn about omeprazole drug interactions backed by FDA labeling. Understand which medications are contraindicated and what to discuss wit...
Evidence-based guide to documented tacrolimus interactions, including contraindicated drug combinations and serious monitoring requirements.
Learn which medications cannot be taken with rifampin. FDA-sourced guide to contraindicated drug pairs, mechanisms, and safe alternatives.